• Lopinavir: From HIV Potency to Repurposing Logic

  2026-08-28

  Lopinavir (ABT-378) combines picomolar HIV protease potency with a valuable cross-pathogen research history. This article explains how to interpret its resistance, serum, pharmacokinetic, and MERS-CoV cell-based evidence when designing antiviral assays.

• Etoposide (VP-16): Reliable Cell Assay Workflows

  2026-08-28

  This scenario-based guide explains how Etoposide (VP-16), SKU A1971, can support reproducible cytotoxicity, proliferation, and DNA damage studies. It covers cell-line-dependent potency, DMSO stock preparation, protocol controls, data interpretation, and practical vendor-selection criteria.

• RNF166, Angiomotins, and YAP in Colorectal Cancer

  2026-08-27

  A 2024 Cell Death and Disease study identifies RNF166 as an E3 ligase that recognizes tankyrase-modified angiomotins, destabilizes these Hippo-pathway regulators, and promotes YAP activation in colorectal cancer. The work connects poly-ADP-ribosylation to substrate recognition and tumor progression, while offering a framework for separating pathway mechanism from phosphorylation-sensitive sample handling.

• Rocket-Like Nanomedicine Restores PDAC Stroma

  2026-08-27

  The reference study develops an acid-responsive, multistage nanomedicine that first remodels pancreatic tumor stroma and then releases gemcitabine for improved intratumoral delivery. Its main innovation is the coordinated use of halofuginone and IPR-803 to restore stromal homeostasis, reduce angiogenic barriers, and produce marked tumor regression in a pancreatic ductal adenocarcinoma mouse model.

• HO-1–ROS Control of HBV Replication: Study Insights

  2026-08-26

  The reference study shows that isochlorogenic acid A (ICAA) suppresses hepatitis B virus replication through several coordinated effects, including reduced viral transcription, cccDNA, particle assembly, and envelopment. Its mechanistic contribution is the connection of HO-1-dependent ROS modulation with altered viral structural-protein chemistry and defective morphogenesis, while also identifying experiments needed to establish causality.

• Moxidectin B3611 for Reproducible Cell Assays

  2026-08-26

  This scenario-led guide explains how Moxidectin (SKU B3611) can be incorporated into fungal viability, proliferation, and cytotoxicity workflows without confusing assay artifacts with biological effects. It connects product handling data with recent evidence on polyene synergy in Candida albicans and provides practical controls for reproducible interpretation.

• Cefotaxime as a Genotype–Phenotype Bridge

  2026-08-25

  Cefotaxime can connect beta-lactam activity, resistance genotype, and plasmid mobility in rigorous bacterial models. This article develops an interpretation-first framework grounded in recent CREC transmission research rather than repeating standard workflow guidance.

• Sulfo-NHS-SS-Biotin for Proteostasis Assays

  2026-08-25

  Sulfo-NHS-SS-Biotin enables reversible surface protein enrichment while preserving a route to distinguish receptor trafficking from total abundance. This article connects cleavable biotinylation chemistry with the proteostasis mechanisms identified in epilepsy-associated GABAA receptor variants.

• DeferoxamineB in Ferroptosis Research Workflows

  2026-08-24

  DeferoxamineB provides a practical iron-chelation control for separating iron-dependent oxidative death from copper-driven mechanisms in tumor-cell assays. This guide shows how to prepare, dose, and troubleshoot Deferoxamine alongside metabolic intervention systems such as SCu/L without overinterpreting rescue results.

• Genistein at the Interface of Signaling and Force

  2026-08-24

  Genistein offers translational researchers a pharmacological lens for separating growth-factor kinase signaling from cytoskeleton-dependent autophagy. This article connects its established activity in cell proliferation inhibition and cancer chemoprevention with emerging mechanotransduction research while defining practical validation strategies and key limitations.

• Batimastat (BB-94) in MMP and NMJ Research

  2026-08-23

  Batimastat (BB-94) gives researchers a practical way to perturb zinc-dependent matrix metalloproteinase activity in cancer, extracellular-matrix, and neuromuscular-junction experiments. Its broad biochemical potency, DMSO compatibility, and preclinical tumor data make it especially useful when paired with spatial imaging, genetic controls, and orthogonal viability assays.

• ARCA Cy5 EGFP mRNA (5-moUTP) Workflow

  2026-08-22

  Use ARCA Cy5 EGFP mRNA (5-moUTP) to separate mRNA delivery from intracellular translation in one experiment. Its covalent Cy5 label supports direct tracking by microscopy or flow cytometry, while EGFP expression provides a functional readout of translational performance.

• MitMAB for Organoid Endocytosis Workflows

  2026-08-22

  MitMAB enables controlled testing of dynamin-dependent uptake in polarized intestinal organoids, helping separate extracellular-vesicle access from true internalization. This practical guide combines model selection, fresh-solution handling, dose optimization, readout design, and troubleshooting for membrane trafficking experiments.

• Ouabain: Selective Na+/K+-ATPase Inhibitor Guide

  2026-08-21

  Ouabain is a precise extracellular probe for separating sodium-pump activity from downstream calcium, vascular, and cardiac responses. This workflow shows how to deploy it in Na+/K+-ATPase inhibition assays, vascular preparations, and translational cardiovascular research while avoiding common interpretation errors.

• Isoproterenol Sulfate Dihydrate in SAN Assays

  2026-08-20

  Isoproterenol sulfate dihydrate provides a controlled pharmacological challenge for human SAN-plexus assembloids. This article explains how to use beta-adrenergic stimulation to separate pacemaker maturation, neural modulation, and assay-specific performance in cardiovascular research.

8402 records 1/561 page Next 12345 下5页 Last page